| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |